OrthoSpace exits for up to $220 million

I reported previously (Jan 2014) on Israel’s OrthoSpace which develops a biodegradable balloon that can be implanted into injured shoulders, preventing friction and alleviating pain. NYSE-listed Stryker Corp. is acquiring OrthoSpace for up to $220 million.


This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *